Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Benard Awuonda"'
Autor:
Catherine A Koss, Diane V Havlir, James Ayieko, Dalsone Kwarisiima, Jane Kabami, Gabriel Chamie, Mucunguzi Atukunda, Yusuf Mwinike, Florence Mwangwa, Asiphas Owaraganise, James Peng, Winter Olilo, Katherine Snyman, Benard Awuonda, Tamara D Clark, Douglas Black, Joshua Nugent, Lillian B Brown, Carina Marquez, Hideaki Okochi, Kevin Zhang, Carol S Camlin, Vivek Jain, Monica Gandhi, Craig R Cohen, Elizabeth A Bukusi, Edwin D Charlebois, Maya L Petersen, Moses R Kamya, Laura B Balzer
Publikováno v:
PLoS Medicine, Vol 18, Iss 2, p e1003492 (2021)
BackgroundOral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, but data are limited on HIV incidence among PrEP users in generalized epidemic settings, particularly outside of selected risk groups. We performed a population-ba
Externí odkaz:
https://doaj.org/article/f196f34e51ac463fa3637a85ee1bb193
Autor:
Joshua Nugent, Benard Awuonda, Carol S. Camlin, Kevin Zhang, Craig R. Cohen, Carina Marquez, Florence Mwangwa, Yusuf Mwinike, Edwin D. Charlebois, Catherine A. Koss, James Peng, Monica Gandhi, Gabriel Chamie, James Ayieko, Diane V. Havlir, Laura B. Balzer, Moses R. Kamya, Katherine Snyman, Tamara D. Clark, Winter Olilo, Hideaki Okochi, Maya L. Petersen, Jane Kabami, Mucunguzi Atukunda, Asiphas Owaraganise, Dalsone Kwarisiima, Elizabeth A. Bukusi, Lillian B. Brown, Douglas Black, Vivek Jain
Publikováno v:
PLoS Medicine
PLoS medicine, vol 18, iss 2
PLoS Medicine, Vol 18, Iss 2, p e1003492 (2021)
PLoS medicine, vol 18, iss 2
PLoS Medicine, Vol 18, Iss 2, p e1003492 (2021)
Background Oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, but data are limited on HIV incidence among PrEP users in generalized epidemic settings, particularly outside of selected risk groups. We performed a population-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cbfc5fb4f927317d4c3acd773f7cc98
Autor:
Carol S. Camlin, Dathan M. Byonanebye, Emmanuel Ssemmondo, Diane V. Havlir, Teri Liegler, Samuel Okiror, Hellen Nakato, Norton Sang, Edwin D. Charlebois, Monica Getahun, Erick Wafula, Elizabeth A. Bukusi, Lillian B. Brown, Theodore Ruel, Yea-Hung Chen, Asiphas Owaraganise, Joshua Schwab, Craig R. Cohen, Jackson Achando, Dalsone Kwarisiima, Mark J. van der Laan, Patrick Omanya, Laura B. Balzer, Benard Awuonda, Catherine A. Koss, Tamara D. Clark, Gabriel Chamie, Douglas Black, Albert Plenty, Carina Marquez, Florence Mwangwa, Joel Kironde, Vivek Jain, James F. Rooney, Moses R. Kamya, James Ayieko, Starley B. Shade, Winter Olilo, Kevin Kadede, Melanie Bacon, Harsha Thirumurthy, Geoff Lavoy, Katherine Snyman, Rachel Burger, Maya L. Petersen, Jane Kabami, Mucunguzi Atukunda
Publikováno v:
The New England journal of medicine, vol 381, iss 3
BACKGROUND: Universal antiretroviral therapy (ART) with annual population testing and a multidisease, patient-centered strategy could reduce new human immunodeficiency virus (HIV) infections and improve community health. METHODS: We randomly assigned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc9b0d7ebbd58062dee2188693cb87b
https://europepmc.org/articles/PMC6748325/
https://europepmc.org/articles/PMC6748325/